Prescription medicines registrations
Search registrations for new medicines including generic medicines, chemical and biological entities (NCE and NBE), biosimilar medicines, biologicals and combinations. You can also search extensions of indications, which describes new uses of medicines.
More information on prescription medicine registration:
- For registration types visit Prescription medicines and biologicals: new registrations.
- For NCE registrations before 2018 visit Prescription medicines: registration of new chemical entities in Australia.
- For EOI registrations before 2018 visit Prescription medicines: new or extended uses, or new combinations of registered medicines.
Last updated
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Search
488 result(s) found, displaying 51 to 75
-
Prescription medicine registrationActive ingredients: dupilumab.
-
Prescription medicine registrationActive ingredients: pembrolizumab.
-
Prescription medicine registrationActive ingredients: enfortumab vedotin.
-
Prescription medicine registrationActive ingredients: enzalutamide.
-
Prescription medicine registrationActive ingredients: nivolumab.
-
Prescription medicine registrationActive ingredients: pembrolizumab.
-
Prescription medicine registrationActive ingredients: pegcetacoplan.
-
Prescription medicine registrationActive ingredients: ivacaftor.
-
Prescription medicine registrationActive ingredients: pegcetacoplan.
-
Prescription medicine registrationActive ingredients: blinatumomab.
-
Prescription medicine registrationActive ingredients: Canakinumab.
-
-
Prescription medicine registrationActive ingredients: concizumab.
-
Prescription medicine registrationActive ingredients: triamcinolone acetonide.
-
Prescription medicine registrationActive ingredients: alectinib hydrochloride.
-
Prescription medicine registrationActive ingredients: Semaglutide.
-
Prescription medicine registrationActive ingredients: miglustat.
-
Prescription medicine registrationActive ingredients: osimertinib mesilate.
-
Prescription medicine registrationActive ingredients: daratumumab.
-
Prescription medicine registrationActive ingredients: fenfluramine hydrochloride.
-
Prescription medicine registrationActive ingredients: Fibrinogen, human thrombin.
-
Prescription medicine registrationActive ingredients: letermovir.
-
-
Prescription medicine registrationActive ingredients: osimertinib mesilate.
-
Prescription medicine registrationActive ingredients: nivolumab.
Last updated